-
Je něco špatně v tomto záznamu ?
Combination of UV and MS/MS detection for the LC analysis of cannabidiol-rich products
A. Nemeškalová, K. Hájková, L. Mikulů, D. Sýkora, M. Kuchař
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články
- MeSH
- Cannabis * MeSH
- chromatografie kapalinová MeSH
- kanabidiol * analýza MeSH
- tandemová hmotnostní spektrometrie MeSH
- tetrahydrokanabinol analýza MeSH
- Publikační typ
- časopisecké články MeSH
Cannabidiol (CBD), a major non-psychoactive cannabinoid, has received a lot of attention due to its potential anti-inflammatory, pain-relieving, and anti-anxiety properties. This has led to a recent boom in CBD-rich commercial products, which are sold without prescription in the form of oils, candies, and cosmetics. Since these products are derived from cannabis, the presence of the psychoactive tetrahydrocannabinol (THC) has to be tested before they enter the market. Here, we present a high-throughput approach based on liquid chromatography coupled to UV and tandem mass spectrometric detection for the determination of CBD, THC, and six other minor cannabinoids (cannabigerolic acid, cannabidivarin, cannabinol, cannabigerol, cannabidiolic acid, and tetrahydrocannabinolic acid) in a wide range of concentrations and in a variety of matrices, including oils, hydrophobic ointments, water-soluble liquids, plant material and gelatinous gummies. Each product was dissolved in a suitable solvent and further diluted to avoid matrix interference. The diluted samples were analyzed by reversed-phase chromatography, coupled to a UV detector followed by a triple quadrupole mass spectrometer, used in the multiple reaction monitoring mode. The UV signal was utilized for the quantification of samples containing high levels of CBD, while the mass spectrometer was used for low levels of THC and other minor cannabinoids. This allowed us to meet the required sensitivity for THC while significantly expanding the range of analyzed CBD, all within an 8-min long chromatographic run. The samples were further quantified using calibration in solvent, the approach was validated, and the validation criteria were met for all matrices except for two (i.e., emulsions and gels). The lower limit of quantification for THC was 0.5 μg/g in gummies, 1.0 μg/g in oils, ointments and liquids, and 5.0 μg/g in plant material. CBD was analyzed in the range of 0.5-60,000 μg/g in gummies, 1-120,000 μg/g in oils, ointments and liquids, and 5-300,000 μg/g in plant material. The developed method was used for the analysis of thirteen real products with a wide range of CBD content, with positive THC findings in twelve of them.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21019938
- 003
- CZ-PrNML
- 005
- 20210830101539.0
- 007
- ta
- 008
- 210728s2020 ne f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.talanta.2020.121250 $2 doi
- 035 __
- $a (PubMed)32887141
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Nemeškalová, Alžběta $u Department of Analytical Chemistry, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic; Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic; National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic
- 245 10
- $a Combination of UV and MS/MS detection for the LC analysis of cannabidiol-rich products / $c A. Nemeškalová, K. Hájková, L. Mikulů, D. Sýkora, M. Kuchař
- 520 9_
- $a Cannabidiol (CBD), a major non-psychoactive cannabinoid, has received a lot of attention due to its potential anti-inflammatory, pain-relieving, and anti-anxiety properties. This has led to a recent boom in CBD-rich commercial products, which are sold without prescription in the form of oils, candies, and cosmetics. Since these products are derived from cannabis, the presence of the psychoactive tetrahydrocannabinol (THC) has to be tested before they enter the market. Here, we present a high-throughput approach based on liquid chromatography coupled to UV and tandem mass spectrometric detection for the determination of CBD, THC, and six other minor cannabinoids (cannabigerolic acid, cannabidivarin, cannabinol, cannabigerol, cannabidiolic acid, and tetrahydrocannabinolic acid) in a wide range of concentrations and in a variety of matrices, including oils, hydrophobic ointments, water-soluble liquids, plant material and gelatinous gummies. Each product was dissolved in a suitable solvent and further diluted to avoid matrix interference. The diluted samples were analyzed by reversed-phase chromatography, coupled to a UV detector followed by a triple quadrupole mass spectrometer, used in the multiple reaction monitoring mode. The UV signal was utilized for the quantification of samples containing high levels of CBD, while the mass spectrometer was used for low levels of THC and other minor cannabinoids. This allowed us to meet the required sensitivity for THC while significantly expanding the range of analyzed CBD, all within an 8-min long chromatographic run. The samples were further quantified using calibration in solvent, the approach was validated, and the validation criteria were met for all matrices except for two (i.e., emulsions and gels). The lower limit of quantification for THC was 0.5 μg/g in gummies, 1.0 μg/g in oils, ointments and liquids, and 5.0 μg/g in plant material. CBD was analyzed in the range of 0.5-60,000 μg/g in gummies, 1-120,000 μg/g in oils, ointments and liquids, and 5-300,000 μg/g in plant material. The developed method was used for the analysis of thirteen real products with a wide range of CBD content, with positive THC findings in twelve of them.
- 650 12
- $a kanabidiol $x analýza $7 D002185
- 650 12
- $a Cannabis $7 D002188
- 650 _2
- $a chromatografie kapalinová $7 D002853
- 650 _2
- $a tetrahydrokanabinol $x analýza $7 D013759
- 650 _2
- $a tandemová hmotnostní spektrometrie $7 D053719
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Hájková, Kateřina $u Department of Analytical Chemistry, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic; Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic; National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic
- 700 1_
- $a Mikulů, Lukáš $u Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic; National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic
- 700 1_
- $a Sýkora, David $u Department of Analytical Chemistry, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic
- 700 1_
- $a Kuchař, Martin $u Forensic Laboratory of Biologically Active Substances, Department of Chemistry of Natural Compounds, University of Chemistry and Technology Prague, Technická 5, 166 28, Prague 6, Czech Republic; National Institute of Mental Health, Topolová 748, 250 67, Klecany, Czech Republic. Electronic address: Martin.Kuchar@vscht.cz
- 773 0_
- $w MED00004484 $t Talanta $x 1873-3573 $g Roč. 219, č. - (2020), s. 121250
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32887141 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20210728 $b ABA008
- 991 __
- $a 20210830101539 $b ABA008
- 999 __
- $a ok $b bmc $g 1690690 $s 1140384
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 219 $c - $d 121250 $e 20200617 $i 1873-3573 $m Talanta $n Talanta $x MED00004484
- LZP __
- $a Pubmed-20210728